Although clinical trials of CFTR-enhancing drugs in COPD patients are in the early stages, a recent study shows that ivacaftor in patients with chronic bronchitis leads to an improvement in symptoms and chlorine levels in the sweat test [76]. This evidence concerns the gene CFTR and chronic obstructive pulmonary disease.